Literature DB >> 29948646

The Role of Disease Conviction: Exploring Its Effects on Chest Pain and Anxiety-Related Models of Non-cardiac Chest Pain.

Caleb M Pardue1, Kamila S White2, Ernest V Gervino3.   

Abstract

The aim of this study was to investigate the role of disease conviction in the chest pain and life interference of patients with non-cardiac chest pain (NCCP), after controlling for anxiety sensitivity and body vigilance. While all three psychological constructs are theoretically implicated and empirically associated with the experience of NCCP, no research has examined the influence of disease conviction in the context of other relevant constructs. The sample included 229 participants with NCCP who were recruited after a medical evaluation failed to elicit an organic explanation for their chest pain. Hierarchical regression analyses revealed that while anxiety sensitivity significantly predicted chest pain severity and interference, only body vigilance contributed significant additional variance to chest pain severity, and only disease conviction contributed significant additional variance to chest pain interference. While anxiety sensitivity, body vigilance, and disease conviction all appear to affect those with NCCP, it seems that their impact is manifest in different domains (i.e., pain perception vs. psychosocial impairment).

Entities:  

Keywords:  Anxiety sensitivity; Disease conviction; Health anxiety; Non-cardiac chest pain

Year:  2019        PMID: 29948646     DOI: 10.1007/s10880-018-9572-9

Source DB:  PubMed          Journal:  J Clin Psychol Med Settings        ISSN: 1068-9583


  49 in total

1.  Illness perceptions, negative emotions, and pain in patients with noncardiac chest pain.

Authors:  Jared I Israel; Kamila S White; Ernest V Gervino
Journal:  J Clin Psychol Med Settings       Date:  2015-03

2.  Disease phobia and disease conviction are separate dimensions underlying hypochondriasis.

Authors:  Thomas A Fergus; David P Valentiner
Journal:  J Behav Ther Exp Psychiatry       Date:  2010-05-20

Review 3.  Unexplained chest pain: when is it panic disorder?

Authors:  R P Fleet; B D Beitman
Journal:  Clin Cardiol       Date:  1997-03       Impact factor: 2.882

4.  Anxiety and depressive symptoms and anxiety sensitivity in youngsters with noncardiac chest pain and benign heart murmurs.

Authors:  Joshua D Lipsitz; Carrie Masia-Warner; Howard Apfel; Zvi Marans; Beth Hellstern; Nicholas Forand; Yosef Levenbraun; Abby J Fyer
Journal:  J Pediatr Psychol       Date:  2004-12

5.  Upper gastrointestinal evaluation of Chinese patients with non-cardiac chest pain.

Authors:  W-M Wong; K C Lai; C P Lau; W H C Hu; W H Chen; B C Y Wong; W M Hui; Y H Wong; H H X Xia; S K Lam
Journal:  Aliment Pharmacol Ther       Date:  2002-03       Impact factor: 8.171

6.  Differentiating hypochondriasis from panic disorder.

Authors:  Wolfgang Hiller; Rolf Leibbrand; Winfried Rief; Manfred M Fichter
Journal:  J Anxiety Disord       Date:  2005

Review 7.  Review article: the burden of illness of non-cardiac chest pain.

Authors:  G D Eslick; D S Coulshed; N J Talley
Journal:  Aliment Pharmacol Ther       Date:  2002-07       Impact factor: 8.171

8.  Panic disorder in patients with chest pain and angiographically normal coronary arteries.

Authors:  B D Beitman; V Mukerji; J W Lamberti; L Schmid; L DeRosear; M Kushner; G Flaker; I Basha
Journal:  Am J Cardiol       Date:  1989-06-01       Impact factor: 2.778

9.  Atypical or nonanginal chest pain. Panic disorder or coronary artery disease?

Authors:  B D Beitman; I Basha; G Flaker; L DeRosear; V Mukerji; L Trombka; W Katon
Journal:  Arch Intern Med       Date:  1987-09

10.  Non-cardiac chest pain: prevalence, risk factors, impact and consulting--a population-based study.

Authors:  G D Eslick; M P Jones; N J Talley
Journal:  Aliment Pharmacol Ther       Date:  2003-05-01       Impact factor: 8.171

View more
  1 in total

1.  A chain mediation model on COVID-19 symptoms and mental health outcomes in Americans, Asians and Europeans.

Authors:  Cuiyan Wang; Agata Chudzicka-Czupała; Michael L Tee; María Inmaculada López Núñez; Connor Tripp; Mohammad A Fardin; Hina A Habib; Bach X Tran; Katarzyna Adamus; Joseph Anlacan; Marta E Aparicio García; Damian Grabowski; Shahzad Hussain; Men T Hoang; Mateusz Hetnał; Xuan T Le; Wenfang Ma; Hai Q Pham; Patrick Wincy C Reyes; Mahmoud Shirazi; Yilin Tan; Cherica A Tee; Linkang Xu; Ziqi Xu; Giang T Vu; Danqing Zhou; Natalie A Chan; Vipat Kuruchittham; Roger S McIntyre; Cyrus S H Ho; Roger Ho; Samuel F Sears
Journal:  Sci Rep       Date:  2021-03-19       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.